Insider: DIVITA CHARLES III CHIEF EXECUTIVE OFFICER - Teladoc Health, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 364,784 | 0 | 364,784 |
| Value | $1,938,826.96 | $0.00 | $1,938,826.96 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/11/2026 | DDS | 27,731 | Direct | COM | $5.49 | $152,243.19 | 364,784 |
| 03/02/2026 | DDS | 50,145 | Direct | COM | $5.12 | $256,591.97 | 327,862 |
| 12/11/2025 | DDS | 17,138 | Direct | COM | $7.63 | $130,836.63 | 201,036 |
| 09/11/2025 | DDS | 16,787 | Direct | COM | $7.59 | $127,435.15 | 179,014 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research